Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Journal of Cell Science
|
February 14, 2012
ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance
Nuria Eritja, Cristina Mirantes, David Llobet, et al.
Reproductive Biology and Endocrinology : RB&E
|
December 13, 2025
Dysregulated autophagy in endometriosis: molecular mechanisms, controversies, and clinical implications
Clara Tellez-Quijorna, Ainhoa Juan-Lopez, Nuria Eritja, et al.
Molecular Oncology
|
April 18, 2013
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
Laura Bergadà, Annabel Sorolla, Andree Yeramian, et al.
The American Journal of Pathology
|
May 15, 2013
Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometrial cells and drives PTEN loss-induced hyperplasic growth
Nuria Eritja, Cristina Mirantes, David Llobet, et al.
Molecular Cancer Therapeutics
|
January 23, 2014
Combinatorial therapy using dovitinib and ICI182.780 (fulvestrant) blocks tumoral activity of endometrial cancer cells
Nuria Eritja, Mónica Domingo, Maria Alba Dosil, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 27, 2008
Loss of heterozygosity in endometrial carcinoma
Ana Velasco, Judit Pallares, Maria Santacana, et al.
Analytical and Quantitative Cytology and Histology
|
September 10, 2009
A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma
Judit Pallares, Maria Santacana, Soraya Puente, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 13, 2008
Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma
Judit Pallarés, Ana Velasco, Nuria Eritja, et al.
Carcinogenesis
|
September 20, 2014
ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas
Lorena Alonso-Alconada, Nuria Eritja, Laura Muinelo-Romay, et al.
Advances in Experimental Medicine and Biology
|
December 3, 2016
Endometrial Carcinoma: Specific Targeted Pathways
Nuria Eritja, Andree Yeramian, Bo-Juen Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Journal of Cell Science
|
February 14, 2012
ERα-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNFα and IL1α in lumen formation and maintenance
Nuria Eritja, Cristina Mirantes, David Llobet, et al.
Reproductive Biology and Endocrinology : RB&E
|
December 13, 2025
Dysregulated autophagy in endometriosis: molecular mechanisms, controversies, and clinical implications
Clara Tellez-Quijorna, Ainhoa Juan-Lopez, Nuria Eritja, et al.
Molecular Oncology
|
April 18, 2013
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
Laura Bergadà, Annabel Sorolla, Andree Yeramian, et al.
The American Journal of Pathology
|
May 15, 2013
Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometrial cells and drives PTEN loss-induced hyperplasic growth
Nuria Eritja, Cristina Mirantes, David Llobet, et al.
Molecular Cancer Therapeutics
|
January 23, 2014
Combinatorial therapy using dovitinib and ICI182.780 (fulvestrant) blocks tumoral activity of endometrial cancer cells
Nuria Eritja, Mónica Domingo, Maria Alba Dosil, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
June 27, 2008
Loss of heterozygosity in endometrial carcinoma
Ana Velasco, Judit Pallares, Maria Santacana, et al.
Analytical and Quantitative Cytology and Histology
|
September 10, 2009
A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma
Judit Pallares, Maria Santacana, Soraya Puente, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 13, 2008
Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma
Judit Pallarés, Ana Velasco, Nuria Eritja, et al.
Carcinogenesis
|
September 20, 2014
ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas
Lorena Alonso-Alconada, Nuria Eritja, Laura Muinelo-Romay, et al.
Advances in Experimental Medicine and Biology
|
December 3, 2016
Endometrial Carcinoma: Specific Targeted Pathways
Nuria Eritja, Andree Yeramian, Bo-Juen Chen, et al.
Page
of 2